EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1

BACKGROUND: As EIF3D is oncogenic in colorectal cancer (CRC) and is associated with multidrug resistance, this study aims to investigate whether and how EIF3D regulates resistance to 5‐fluorouracil (5‐Fu) in CRC. METHODS: EIF3D‐associated genes in CRC were predicted using bioinformatics tools. CRC cells and nude mice received 5‐Fu treatment. Then, the impacts of EIF3D and the interaction between EIF3D and RUVBL1 on cell viability, colony formation, apoptosis, and DNA damage were detected through MTT, colony formation, flow cytometry, and immunofluorescence assays, and those on in vivo tumorigenesis through murine xenograft assay. IC50 value of 5‐Fu for CRC cells was determined by probit regression analysis. Expressions of EIF3D, eIF4E, EIF3D‐associated genes, γH2AX, Bcl‐2, Bax, and Cleaved Caspase‐3/Caspase‐3 in CRC tissues, cells, and/or xenograft tumors were analyzed by qRT‐PCR and/or Western blot. RESULTS: EIF3D and RUVBL1 were highly expressed and positively correlated with CRC tissues/cells. In CRC cells, except for eIF4E, both EIF3D and RUVBL1 levels were upregulated by 5‐Fu treatment; in addition to that, RUVBL1 level was downregulated by EIF3D silencing rather than eIF4E. Meanwhile, EIF3D silencing diminished IC50 value of 5‐Fu and potentiated 5‐Fu‐induced viability decrease, colony formation inhibition, apoptosis promotion, Bcl‐2 downregulation, and γH2AX, Bax, and Cleaved Caspase‐3/Caspase‐3 upregulation but reversed 5‐Fu‐triggered RUVBL1 upregulation. RUVBL1 overexpression offsets EIF3D silencing‐induced viability decrease and apoptosis promotion of 5‐Fu‐treated CRC cells, and tumorigenesis suppression and apoptosis promotion in 5‐Fu‐treated mice. CONCLUSION: EIF3D promotes resistance to 5‐Fu in CRC through upregulating RUVBL1 level.